Poon To Retire From J&J; New Presidents At CTI Europe, Inotek & Synageva
President & CEO
You may also be interested in...
In its latest restructuring move, announced Nov. 15, Johnson & Johnson - a model for diversified health care companies - is focusing on providing integrated health solutions rather than individual products
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials